Urinary renal epithelial cells can be used for <i>NPHP1</i> phenotyping and a personalized therapeutic strategy

Sudhindar, Praveen;Olinger, Eric;Sentell, Zachary;Mabillard, Holly;Arcila-Galvis, Juliana;et.al.
(2025) Journal of Cell Science — Vol. 138, n° 20 (2025)

Files

DownloadCombinedArticleAndSupplmentPdf.pdf
  • Open Access
  • Adobe PDF
  • 13.79 MB

Details

Authors
  • Sudhindar, PraveenTranslational and Clinical Research Institute 1 , Faculty of Medical Sciences , , Central Parkway, Newcastle upon Tyne, NE1 3BZ ,
    Author
  • Olinger, Ericorcid-logoTranslational and Clinical Research Institute 1 , Faculty of Medical Sciences , , Central Parkway, Newcastle upon Tyne, NE1 3BZ and 2Center for Human Genetics, Cliniques Universitaires Saint-Luc, Brussels, Belgium
    Author
  • Sentell, Zacharyorcid-logoBiosciences Institute 3 , Faculty of Medical Sciences , , Central Parkway, Newcastle upon Tyne, NE1 3BZ ,
    Author
  • Mabillard, Hollyorcid-logoTranslational and Clinical Research Institute 1 , Faculty of Medical Sciences , , Central Parkway, Newcastle upon Tyne, NE1 3BZ ,
    Author
  • Arcila-Galvis, Julianaorcid-logoBiosciences Institute 3 , Faculty of Medical Sciences , , Central Parkway, Newcastle upon Tyne, NE1 3BZ ,
    Author
Show more
Abstract
Nephronophthisis (NPHP) is a recessive tubulointerstitial nephropathy and a leading genetic cause of kidney failure in children and young adults. The most common genetic cause is a homozygous deletion of NPHP1, which encodes nephrocystin-1, a protein essential for primary cilium structure and cell junctions. Using personalized medicine and deep phenotyping, we investigated a family with three siblings carrying a homozygous NPHP1 deletion. We compared kidney biopsy tissue and human urine-derived renal epithelial cells (hURECs) from these individuals. Bulk RNA-seq on patient hURECs revealed altered expression in EGFR signalling, extracellular components and adherens junctions, which is consistent with the known roles for nephrocystin-1. Treatment with alprostadil, a proposed NPHP therapy, increased ciliation but worsened ciliary elongation. By contrast, the EGFR kinase inhibitor AG556 rescued of ciliary length and morphology. Transcriptional profiling post-treatment showed AG556 reversed the disease signature more effectively that alprostadil. These findings suggest that EGFR inhibition might offer a more promising therapeutic strategy for NPHP1-associated renal ciliopathy, warranting further testing in in vivo models before clinical application.
Affiliations

Citations

Sudhindar, P., Olinger, E., Sentell, Z., Mabillard, H., Dicka, B., Wood, K., Rutland, D., Collins, C., Trevisan-Herraz, M., Sayer, J., & Arcila-Galvis, J. (2025). Urinary renal epithelial cells can be used for <i>NPHP1</i> phenotyping and a personalized therapeutic strategy. Journal of Cell Science, 138(20). https://doi.org/10.1242/jcs.264141 (Original work published 2025)